Hillsdale Investment Management Inc. Acquires 160 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hillsdale Investment Management Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 27.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 744 shares of the healthcare conglomerate’s stock after buying an additional 160 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in UnitedHealth Group were worth $376,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Sfmg LLC boosted its position in shares of UnitedHealth Group by 21.7% in the fourth quarter. Sfmg LLC now owns 1,871 shares of the healthcare conglomerate’s stock valued at $946,000 after acquiring an additional 334 shares during the period. Intellus Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $824,000. Forefront Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $2,324,000. Plancorp LLC grew its position in UnitedHealth Group by 15.4% during the fourth quarter. Plancorp LLC now owns 12,805 shares of the healthcare conglomerate’s stock worth $6,478,000 after buying an additional 1,711 shares in the last quarter. Finally, Runnymede Capital Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $70,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.0 %

Shares of NYSE UNH opened at $516.94 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $509.71 and a two-hundred day simple moving average of $546.15. The firm has a market capitalization of $472.85 billion, a PE ratio of 33.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.